HealthStream (NASDAQ:HSTM) Price Target Raised to $29.00 at Canaccord Genuity Group

HealthStream (NASDAQ:HSTM - Free Report) had its price objective increased by Canaccord Genuity Group from $28.00 to $29.00 in a research report report published on Wednesday, Benzinga reports. The brokerage currently has a hold rating on the technology company's stock.

A number of other equities analysts have also recently issued reports on the company. Barclays increased their target price on HealthStream from $32.00 to $34.00 and gave the stock an "overweight" rating in a report on Wednesday. Craig Hallum raised shares of HealthStream to a "strong-buy" rating in a research report on Thursday, October 17th. Finally, StockNews.com cut shares of HealthStream from a "strong-buy" rating to a "buy" rating in a research report on Wednesday, July 24th. Two research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, HealthStream has a consensus rating of "Moderate Buy" and an average price target of $31.50.

HealthStream Stock Down 4.8 %

HSTM traded down $1.44 during midday trading on Wednesday, hitting $28.63. The company had a trading volume of 163,778 shares, compared to its average volume of 112,590. The stock's 50 day moving average price is $28.70 and its 200 day moving average price is $27.88. HealthStream has a 52 week low of $22.84 and a 52 week high of $31.15. The company has a market capitalization of $870.29 million, a price-to-earnings ratio of 49.36, a PEG ratio of 4.25 and a beta of 0.36.

HealthStream (NASDAQ:HSTM - Get Free Report) last issued its earnings results on Monday, October 21st. The technology company reported $0.19 EPS for the quarter, beating analysts' consensus estimates of $0.13 by $0.06. The business had revenue of $73.10 million during the quarter, compared to analyst estimates of $73.53 million. HealthStream had a return on equity of 5.19% and a net margin of 6.26%. The firm's revenue was up 4.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.13 EPS. Research analysts predict that HealthStream will post 0.56 EPS for the current year.

HealthStream Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Monday, November 4th will be given a dividend of $0.028 per share. This represents a $0.11 dividend on an annualized basis and a dividend yield of 0.39%. The ex-dividend date of this dividend is Monday, November 4th. HealthStream's payout ratio is currently 18.97%.

Insider Buying and Selling

In other HealthStream news, Director Tate Deborah Taylor sold 1,400 shares of HealthStream stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $28.53, for a total transaction of $39,942.00. Following the transaction, the director now owns 22,326 shares of the company's stock, valued at $636,960.78. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Tate Deborah Taylor sold 1,400 shares of the firm's stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $28.53, for a total transaction of $39,942.00. Following the completion of the sale, the director now directly owns 22,326 shares of the company's stock, valued at $636,960.78. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Kevin P. O'hara sold 3,000 shares of the business's stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total transaction of $84,090.00. Following the completion of the transaction, the senior vice president now directly owns 9,527 shares in the company, valued at $267,041.81. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 20.60% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Quadrature Capital Ltd purchased a new position in HealthStream in the fourth quarter valued at approximately $311,000. Diversified Trust Co bought a new position in shares of HealthStream during the 1st quarter worth $213,000. Allspring Global Investments Holdings LLC increased its holdings in HealthStream by 82.4% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 34,135 shares of the technology company's stock worth $910,000 after acquiring an additional 15,425 shares during the last quarter. Wakefield Asset Management LLLP bought a new stake in HealthStream in the 1st quarter valued at about $909,000. Finally, Sei Investments Co. lifted its holdings in HealthStream by 2.3% during the first quarter. Sei Investments Co. now owns 171,427 shares of the technology company's stock valued at $4,570,000 after purchasing an additional 3,926 shares during the last quarter. 69.58% of the stock is owned by institutional investors.

HealthStream Company Profile

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.